Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-07

Clinical Trial Update: Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial assessing effectiveness, safety, and tolerability of oxymorphone immediate-release oral liquid in pediatric post-operative pain; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone IR oral liquid (oxymorphone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Post Operative Pain | Phase 3 | Status: COMPLETED | Results posted: 2019-05-07